Dimensional Fund Advisors LP Has $6.76 Million Stock Holdings in Strata Critical Medical $SRTA

Key Points

• Dimensional Fund Advisors increased its Strata Critical Medical stake by 11.9% in the first quarter, holding 1.62 million shares worth approximately $6.76 million, or 1.86% of the company.
• Other institutional investors also added shares, bringing total institutional and hedge-fund ownership to 47.36%. Insiders sold 116,931 shares worth $687,184 during the quarter, primarily to cover tax withholding on vested equity awards.
• SRTA shares opened at $5.94, within a 52-week range of $3.85 to $6.50. Analysts maintain a “Moderate Buy” consensus with an average price target of $8.00, although Weiss Ratings downgraded the stock’s hold assessment.

Dimensional Fund Advisors LP boosted its holdings in shares of Strata Critical Medical (NASDAQ:SRTA - Free Report) by 11.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,617,104 shares of the company's stock after purchasing an additional 172,154 shares during the period. Dimensional Fund Advisors LP owned about 1.86% of Strata Critical Medical worth $6,759,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Seelaus Asset Management LLC lifted its position in shares of Strata Critical Medical by 32.7% during the 1st quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company's stock worth $102,000 after buying an additional 6,000 shares during the period. Granite Investment Partners LLC grew its position in Strata Critical Medical by 77.0% in the first quarter. Granite Investment Partners LLC now owns 18,181 shares of the company's stock valued at $76,000 after acquiring an additional 7,911 shares during the period. Finally, Principal Financial Group Inc. bought a new stake in Strata Critical Medical in the first quarter valued at $537,000. 47.36% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Strata Critical Medical

In other news, CEO William A. Heyburn sold 31,671 shares of the firm's stock in a transaction on Monday, June 8th. The stock was sold at an average price of $5.87, for a total value of $185,908.77. Following the completion of the sale, the chief executive officer directly owned 1,548,997 shares in the company, valued at approximately $9,092,612.39. This trade represents a 2.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Amir Cohen sold 4,655 shares of the company's stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $5.87, for a total transaction of $27,324.85. Following the transaction, the chief accounting officer owned 146,608 shares in the company, valued at approximately $860,588.96. This trade represents a 3.08% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 116,931 shares of company stock worth $687,184. Insiders own 15.50% of the company's stock.

Strata Critical Medical Trading Up 2.6%

Shares of SRTA opened at $5.94 on Tuesday. The company has a fifty day simple moving average of $5.46. Strata Critical Medical has a 52-week low of $3.85 and a 52-week high of $6.50. The company has a market cap of $513.99 million, a P/E ratio of -74.25 and a beta of 2.25.

Analysts Set New Price Targets

Separately, Weiss Ratings lowered Strata Critical Medical from a "hold (c)" rating to a "hold (c-)" rating in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $8.00.

Strata Critical Medical Company Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source